SCHEMBL31487735

SCHEMBL31487735

CC(C)(C)OC(=O)N1CCC(c2cnn3cc(-c4cncs4)cnc23)CC1

nearest known ligand 0.54

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
▸ GPR119 Q8TDV5 12/20 0.54
▸ RET P07949 2/20 0.42
▸ HPGDS O60760 1/20 0.41
▸ HPGD P15428 2/20 0.40
▸ KDM4E B2RXH2 2/20 0.40
▸ MAPT P10636 2/20 0.40
▸ MEN1 O00255 1/20 0.40
▸ USP2 O75604 1/20 0.40
▸ ALDH1A1 P00352 1/20 0.40
▸ GAA P10253 1/20 0.40
▸ TSHR P16473 1/20 0.40
▸ MAPK1 P28482 1/20 0.40
▸ KMT2A Q03164 1/20 0.40
▸ NPSR1 Q6W5P4 1/20 0.40
▸ HSD17B10 Q99714 1/20 0.40
▸ TDP1 Q9NUW8 1/20 0.40
▸ L3MBTL1 Q9Y468 1/20 0.40
▸ THRB P10828 1/20 0.39
▸ PTPN2 P17706 1/20 0.39
▸ PTPN1 P18031 1/20 0.39

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL31487843 0.83 RET (0.55) GPR119RETHPGDS
SCHEMBL31487895 0.81 DDB1 (0.47) GPR119RETHPGDS
SCHEMBL31487734 0.81 GPR119 (0.52) GPR119RETHPGDSKDM4EMAPT
SCHEMBL31487760 0.81 GPR119 (0.47) GPR119RETHPGDSHPGDKDM4E
SCHEMBL31487905 0.81 GPR119 (0.35) GPR119KDM4EHSD17B10
SCHEMBL31487766 0.80 GPR119 (0.48) GPR119RETHPGDSHPGDKDM4E
SCHEMBL31487815 0.76 NR3C1 (0.43) GPR119RETHPGDSHPGDKDM4E
SCHEMBL31487761 0.75 ACVR1 (0.41) RET
SCHEMBL31487820 0.75 RET (0.47) GPR119RETHPGDKDM4EMEN1
SCHEMBL31487807 0.75 GPR119 (0.44) GPR119RETHPGDKDM4EMAPT

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 1 patent. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
WO-2025089370-A1 COMPOUNDS AS CSF1R INHIBITORS OTSUKA PHARMACEUTICAL CO., LTD. (JP) 2025-05-01 — — WO disclosed
Send feedback